| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:20512242:1748 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:20512242:1748?format=raw |
LEADER: 01748cam a2200349 a 4500
001 3574132
005 20221020083156.0
008 930112s1992 dcu b f000 0 eng d
020 $a0160397863
035 $a(OCoLC)ocm27235080
035 $9AJS0397DC
035 $a3574132
040 $dGPO$dDLC$dMvI
043 $an-us---
074 $a1019-A$b1019-B (MF)
086 0 $aY 4.EN 2/3:102-161
088 $aSerial no. 102-161 (United States. Congress. House. Committee on Energy and Commerce)
099 $aY 4.EN 2/3:102-161
110 1 $aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Health and the Environment.$0http://id.loc.gov/authorities/names/n81087545
245 10 $aUser fees for prescription drugs :$bhearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992.
260 $aWashington :$bU.S. G.P.O. :$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$c1992.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aDistributed to some depository libraries in microfiche.
500 $aShipping list no.: 93-0122-P.
504 $aIncludes bibliographical references.
500 $a"Serial no. 102-161."
610 10 $aUnited States.$bFood and Drug Administration.$0http://id.loc.gov/authorities/names/n80126147
650 0 $aPharmaceutical industry$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2008108871
650 0 $aFees, Administrative$zUnited States.
650 0 $aUser charges$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2008113154
852 30 $boff,docs$hY 4.EN 2/3:102-161